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Acetylcholine (ACh), released from axonal terminals of motor neurons in neuromuscular
junctions regulates the efficacy of neurotransmission through activation of presynaptic
nicotinic and muscarinic autoreceptors. Receptor-mediated presynaptic regulation could
reflect either direct action on exocytotic machinery or modulation of Ca2+ entry
and resulting intra-terminal Ca2+ dynamics. We have measured free intra-terminal
cytosolic Ca2+ ([Ca2+]i) using Oregon-Green 488 microfluorimetry, in parallel with
voltage-clamp recordings of spontaneous (mEPC) and evoked (EPC) postsynaptic
currents in post-junctional skeletal muscle fiber. Activation of presynaptic muscarinic
and nicotinic receptors with exogenous acetylcholine and its non-hydrolized analog
carbachol reduced amplitude of the intra-terminal [Ca2+]i transients and decreased
quantal content (calculated by dividing the area under EPC curve by the area under
mEPC curve). Pharmacological analysis revealed the role of muscarinic receptors of M2
subtype as well as d-tubocurarine-sensitive nicotinic receptor in presynaptic modulation
of [Ca2+]i transients. Modulation of synaptic transmission efficacy by ACh receptors
was completely eliminated by pharmacological inhibition of N-type Ca2+ channels. We
conclude that ACh receptor-mediated reduction of Ca2+ entry into the nerve terminal
through N-type Ca2+ channels represents one of possible mechanism of presynaptic
modulation in frog neuromuscular junction.
Keywords: neuromuscular synapse, calcium transient, presynaptic acetylcholine receptors, muscarinic receptors,
nicotinic receptors, N-type Ca channels, quantum secretion of acetylcholine
INTRODUCTION
Acetylcholine (ACh) when released from nerve endings upon action potential-driven
depolarization, not only triggers postsynaptic response in muscle cell, but also regulates its own
secretion from presynaptic terminal (Ciani and Edwards, 1963; Parnas et al., 2000; Tomas et al.,
2014). This presynaptic regulation has an important for reliability of synaptic transmission. It has
been shown that various subtypes of muscarinic and nicotinic acetylcholine receptors are expressed
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in motor nerve endings and they modulate release of ACh into
the synaptic cleft (Bowman et al., 1990; Miller, 1990; Tomas
et al., 2014). The direct and indirect Ca2+ influx resulting from
the activation of neuronal nicotinic acetylcholine receptors can
modulate presynaptic neurotransmitter release (Shen and Yakel,
2009). Two subtypes of muscarinic receptors are involved in the
ACh release modulation: the M1 receptor mediates enhancement
of ACh release, while the M2 is involved in inhibition of
release (Slutsky et al., 1999). Muscarinic agonists have been
shown to decrease the number of quanta released in response
to stimulation of motor nerve (Arenson, 1989; Slutsky et al.,
1999; Samigullin et al., 2014). Muscarinic receptors can also
be activated in the absence of stimulation during spontaneous
neurotransmitter release (Kupchik et al., 2008).
Although this phenomenon has received a significant research
attention in the past (Nikol’ski˘ı and Giniatullin, 1979; Wessler,
1989; Macleod et al., 1994; Van der Kloot et al., 1997; Nikolsky
et al., 2004), fine details of ACh-dependent presynaptic regulation
remain obscure. Both direct action of ACh on exocytotic
machinery (Linial et al., 1997) and inhibition of presynaptic Ca2+
entry (Wu and Saggau, 1997; Parnas et al., 2000; Khaziev et al.,
2012) have been suggested. The latter possibility, being seemingly
logical, has not been analyzed in detail. The present study was
designed to investigate the role of presynaptic calcium influx in
autoregulation of ACh secretion by presynaptic receptors in the
frog neuromuscular junction.
MATERIALS AND METHODS
Experimental Preparation and Ethical
Approval
Experiments were performed on isolated nerve-muscle
preparations of musculus cutaneous pectoris from the frog
Rana ridibunda. The experimental procedures were performed
in accordance with the guidelines for use of laboratory animals
of Kazan Federal University and Kazan Medical University, in
compliance with the NIH Guide for Care and Use of Laboratory
Animals. Experimental protocols met the requirements of the
European Communities Council Directive 86/609/EEC and were
approved by the Ethical Committee of KazanMedical University.
Intracellular Ca2+ monitoring
Cytosolic concentration of ionized Ca2+ ([Ca2+]i) in nerve
endings was monitored using fluorescent microfluorimetry
(Tsien, 1989). Each nerve-muscle preparation was loaded with
Ca2+-sensitive dye by soaking nerve stump in 50mM solution
of fluorescent Ca2+-indicator Oregon Green 488 BAPTA-1
Hexapotassium Salt (Molecular Probes, Eugene, Oregon, USA);
for details of loading technique see (Peng and Zucker, 1993; Wu
and Betz, 1996; Tsang et al., 2000; Samigullin et al., 2015). At
the end of loading protocol, all terminals in the proximal part
of the nerve trunk had sufficient levels of fluorescence. It has
been estimated that the intra-terminal concentration of the probe
varied between 40 and 150 µM (Suzuki et al., 2000).
Abbreviations: Ach, Acetylcholine; EPC, evoked postsynaptic currents; mEPC,
spontaneous postsynaptic currents.
The fluorescent probe by definition binds Ca2+ and hence
may affect both [Ca2+]i dynamics and physiology of the
neuromuscular junction. Our own observations (Samigullin
et al., 2015) as well as observations of others (Wu and Betz,
1996) failed to detect any appreciable influence of loaded Ca2+
probe on the amplitude of the postsynaptic response or on the
frequency of the miniature end-plate potentials. Nonetheless
we additionally performed control experiments to compare
spontaneous endplate currents (mEPC) and quantal release
before and after Ca2+ probe loading. It appeared that Ca2+
probe affects neither; the mEPC frequency was 0.32 ± 0.03Hz
(n = 4, P < 0.05) before and 0.32 ± 0.15Hz (n = 4, P < 0.05)
after loading of the probe; similarly the quantal content was
1.06 ± 0.09 (n = 3, P < 0.05) and 0.99 ± 0.07 (n = 3,
P < 0.05). We may conclude, therefore adding Ca2+ probe
into the cytosol of the terminal does not affect physiological
parameters of neurotransmission.
Neuromuscular preparations were continuously perfused with
the Ringer solution of the following content (in mM): NaCl–
113, KCl–2.5, NaHCO3–3, MgCl2–6, CaCl2–0.9; pHwas adjusted
to 7.4. Low extracellular Ca2+ (0.9 mM) and high level of
external MgCl2 (6 mM) were used to block muscle contraction.
All experiments were performed under these conditions except
the serie with decreasing extracellular Ca2+. Experiments were
performed at 20.0± 0.3◦C.
Fluorescent signal was recorded using photometric
setup on the base of Olympus BX-51 microscope with x60
water-immersion objective connected to photodiode S1087
(Hamamatsu, Japan) as described in Sinha and Saggau
(1999) and Samigullin et al. (2010, 2015). The region for
recording was selected by optical viewfinder (Till Photonics,
Munich, Germany). Excitation light (488 nm) was generated by
Polychrome V (Till Photonics, Munich, Germany). To minimize
bleaching of the dye and decrease background fluorescence,
the recording area of nerve terminal was restricted by an iris
diaphragm. Illumination was controlled by a shutter with a
typical exposure time of 400 ms and a delivery rate of 0.5 Hz.
Motor nerve was electrically stimulated by rectangular voltage
pulses of 0.2 ms in duration and supra-threshold amplitude at
a frequency of 0.5 Hz using the “suction” electrode described
earlier (Kazakov et al., 2015). The photodiode signal was
digitized by the ADC Digidata 1440A (Molecular Devices,
USA) with sampling rate 10.256 kHz. Fluorescence recordings,
illumination and electrical stimulation were all controlled by
WinWCP software (Strathclyde University, Glasgow, UK).
The peak amplitude of [Ca2+]i transients was measured and
changes in fluorescence are represented as 1F/F0 (the change in
fluorescence intensity relative to the background fluorescence
as a percentage). For each experiment, about 60 fluorescence
responses were averaged.
Electrophysiological Recordings
Spontaneous and evoked endplate currents (mEPC and EPC,
respectively) were recorded with a two-electrode voltage clamp
technique at a holding potential of −60 mV. Intracellular
microelectrodes (5–10 M in resistance) were filled with 2.5 M
KCl. Currents were recorded using Axoclamp 900A amplifier and
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digitized by Digidata 1440A (Molecular Devices, USA) under
control of Clampex software v. 10.5. Quantum content of EPCs
was calculated by dividing the area under EPC curve by the area
under mEPC curve.
Chemicals
All reagents were obtained from Sigma (Saint Louis, Missouri,
USA). Drugs were diluted in extracellular solution to get the
following final concentrations: carbachol (10 µM), acetylcholine
(100µM), neostigmine (1µM), atropine (1µM), d-tubocurarine
(10 µM), muscarine (10 µM), nicotine (10 µM), pirenzepine
(100 nM), methoctramine (10 nM), mecamylamine (640 nM–6.9
µM), metillikakonitin (10 nM), ω-conotoxin GVIA (300 nM).
Data Analysis
Experimentally measured relative amplitudes were tested for
normal distribution. Statistical significance of relative amplitudes
we assessed by Student’s t-test for pairwise variant. Then data
are presented as mean (%) ± SEM. Values of P < 0.05 were
considered significant.
RESULTS
Acetylcholine and Carbachol Reduce
[Ca2+]i Transients and Quantal Content of
EPC
Application of 10 µM of carbachol decreased amplitudes of
mEPC and EPC by 26 ± 5% (n = 4, P < 0.05) and 61 ± 8%
(n = 4, P < 0.05), respectively (Figure 1A). Carbachol also
reduced quantal content by 46 ± 10% (n = 4, P < 0.05)
as compared to control (Figure 1B). 100 µM ACh attenuated
quantal content by 49 ± 7% (n = 18, P < 0.05, Figure 1B).
Both carbachol and ACh also attenuated amplitude of [Ca2+]i
transients by 11 ± 1% (n = 5, P <0.05) and 13 ± 4% (n = 6,
P < 0.05,) respectively (Figures 1C,D). Since inhibitory effects
of exogenous acetylcholine and carbachol were similar, we used
carbachol in all subsequent experiments to activate nicotinic and
muscarinic receptors simultaneously. Nicotine and muscarine,
however, were used to selectively activate respective receptors
types. Also, carbachol is not hydrolysed by acetylcholine esterase,
and hence its concentration remains constant over the entire
experiment duration.
[Ca2+]i Transients and Quantal Release
after Changing Driving Force for Ca2+
Entry into Nerve Terminal
We were interested to elucidate whether a 11% decrease in the
peak magnitude of [Ca2+]i transient is sufficient to account for a
46% decline in neurotransmitter release observed with carbachol
(Figures 1A–C). For this purpose, we have reduced the external
concentration of Ca2+ from 0.6 to 0.3 mM and found that it
decreased the evoked [Ca2+]i transient by 23 ± 4% (n = 3)
(Figure 2A). In parallel with this, quantal content dropped by
80 ± 4% (Figure 2B). Thus, carbachol-induced decrease in the
size of evoked [Ca2+]i transients is more than sufficient to
produce inhibition of neurotransmitter release observed in our
experiments earlier. Similar observations were made previously
while studying quantal content and [Ca2+]i transients under
activation of cannabinoid receptors (Newman et al., 2007).
[Ca2+]i Transient Modulation by Muscarine
and Nicotine
Exposure to 10 µM nicotine reduced the amplitude of [Ca2+]i
transient by 15 ± 3% (n = 6, P < 0.05, Figure 3B). Application
of 10µMmuscarine decreased the amplitude of [Ca2+]i transient
by 8 ± 2% (n = 5, P < 0.05, Figure 3B). Nicotinic antagonist d-
tubocurarine (10µM) partially but significantly reduced nicotine
effect on the [Ca2+]i transient, while incubation with muscarinic
blocker atropine (1µM) completely eliminated presynaptic effect
of muscarine (Figure 3B). In the presence of atropine (1 µM),
carbachol (10 µM) reduced [Ca2+]i transient by 9 ± 5% (n = 6,
P < 0.05, Figure 3B), while in the presence of d-tubocurarine
(10 µM)—by 18 ± 9% (n = 4, P < 0.05, Figure 3B). Pre-
incubation with the mixture of d-tubocurarine (10 µM) and
atropine (1 µM), completely eliminated carbachol effects on
[Ca2+]i transients (Figures 3A,B).
Nicotinic blocker d-tubocurarine did not change the
inhibitory effect of muscarine alone—it reduced [Ca2+]i
transients by 8 ± 2% (n = 7, P < 0.05, Figures 4A,B). Similarly,
blockade ofmuscarinic receptors by atropine did not significantly
affect the inhibitory action of nicotine –[Ca2+]i transients were
reduced by 8± 3% (n= 7, P < 0.05, Figures 4C,D).
Identification of Muscarinic Receptor
Subtypes That Mediate the Effects of
Cholinomimetics
M1-receptor blocker pirenzepine (100 nM) by itself decreased
[Ca2+]i transients by 14 ± 7% (n = 5, P < 0.05, Figures 5A,B).
Addition of muscarine further decreased the amplitude
of [Ca2+]i transient (Figures 5A,B). Exposure to 10 nM
methoctramine (specific blocker of muscarinic M2 receptor
subtypes), did not affect [Ca2+]i transients by itself. In the
presence of methoctramine, however, the inhibitory action
of muscarine on [Ca2+]i transient was completely eliminated
(Figures 5C,D).
Identification of Nicotinic Receptor
Subtypes That Mediate the Effects of
Cholinomimetics
In these experiments nicotine was used as a specific agonist
of nicotinic acetylcholine receptors. Mecamylamine is able to
block various subtypes of nicotinic receptors depending on
concentration within the range from 640 nM to 6.9 µM
(Papke et al., 2001; Rabenstein et al., 2006; Ostroumov et al.,
2008). Next, we tested the effects of different concentrations of
mecamylamine. Application of 640 nMmecamylamine increased
[Ca2+]i transient amplitude by 18 ± 3% (n = 5, P < 0.05,
Figure 6). When 640 nM mecamylamine was applied with
nicotine [Ca2+]i transient amplitude decreased by 9± 4% (n= 5,
P< 0.05, Figure 6). At 2.5µM,mecamylamine increased [Ca2+]i
transient amplitude by 16 ± 2% (n = 3, P < 0.05, Figure 6),
while subsequent addition of nicotine reduced [Ca2+]i transient
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FIGURE 1 | Acetylcholine and carbachol reduce [Ca2+]i transients and the EPC quantal content. (A) Representative EPCs in control conditions and in the
presence of 10 µM carbachol. (B) Quantal content in the presence of 10 µM carbachol or 100 µM ACh. (C) [Ca2+]i transients in control and in the presence of 10
µM carbachol. (D) Amplitude of [Ca2+]i transients in the presence of carbachol and acetylcholine as % of control (control set as100%). Abbreviations: Contr, control;
CCh, carbachol; ACh, acetylcholine. *P < 0.05 vs. control saline; n = 4–6.
FIGURE 2 | Role of Ca2+ entry in generation of [Ca2+]i transients and regulation of quantal release. (A) [Ca
2+]i transients at two different Ca
2+
concentrations in extracellular solution. Amplitude of [Ca2+]i transients at 0.6 mM Ca
2+ is set as 100%. (B) Average quantum content of EPC at two different
concentrations of extracellular Ca2+. *P < 0.05 vs. control saline; n = 3.
amplitude by 19 ± 4% (n = 3, P < 0.05, Figure 6). At 3.6
µM mecamylamine increased [Ca2+]i transient by 23 ± 7%
(n = 6, P < 0.05, Figure 6), whereas its combined application
with nicotine decreased [Ca2+]i transient by 14 ± 2% (n = 6, P
< 0.05, Figure 6). Finally, at 6.9 µM, mecamylamine increased
[Ca2+]i transient by 15 ± 8% (n = 3, P < 0.05, Figure 6), while
combined application with nicotine decreased [Ca2+]i transient
amplitude by 8± 2% (n= 3, P< 0.05, Figure 6). Metillikakonitin
is a specific blocker of the α7-nicotinic receptor subunit. Adding
metillikakonitin at 10 nM increased the amplitude of [Ca2+]i
transient by 13 ± 11% (n = 5, P < 0.05, Figure 6), while
subsequent addition of nicotine decreased [Ca2+]i transients by
11± 5% (n= 6, P < 0.05, Figure 6).
Voltage-Gated Ca2+ Channels Involved in
Carbachol Modulation of [Ca2+]i dynamics
Since both acetylcholine and carbachol reduce [Ca2+]i transient
and quantum content of endplate currents, we suggested that
cholinergic modulation of neurotransmitter release could result
from attenuated Ca2+ entry into motor nerve endings (Khaziev
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FIGURE 3 | Modulation of [Ca2+]i transient by muscarine and nicotine. (A) [Ca
2+]i transient in the presence of carbachol (10 µM) after pre-treatment with the
mixture of atropine (1 µM) and d-tubocurarine (10 µM). (B) Average amplitudes of [Ca2+]i transient normalized to the control in the presence of nicotine (10 µM); in
the presence of nicotine after pre-treatment with d-tubocurarine (10 µM); in the presence of muscarine (10 µM); in the presence of muscarine after pre-treatment with
atropine (1 µM), in the presence of carbachol (10 µM) after pre-treatment with d-tubocurarine (10 µM), in the presence of carbachol (10 µM) after pre-treatment with
atropine (1 µM) and in the presence of carbachol after pre-treatment with the mixture of atropine (1 µM) and d-tubocurarine (10 µM). Abbreviations: d-TC,
d-tubocurarine; Atr, atropine; CCh, carbachol; Nic, nicotine (10 µM); Musc, muscarine (10 µM). *P < 0.05 vs. control saline; n = 4–7.
FIGURE 4 | Specific effects of activation of muscarinic and nicotinic receptors on [Ca2+]i transients. (A) [Ca
2+]i transients in the presence of muscarine
(10 µM) after blockade of nicotinic receptors by d-tubocurarine (10 µM). (B) Average amplitude of [Ca2+]i transient in the presence of muscarine (10 µM) after
blockade of nicotinic receptors by tubocurarine (10 µM). (C) Amplitude of [Ca2+]i transient in the presence of nicotine (10 µM) after blockade of muscarinic receptors
by atropine (1 µM). (D) Average amplitude of [Ca2+]i transient in presence of nicotine when muscarinic receptors are blocked by atropine. Abbreviations: d-TC,
d-tubocurarine; Atr, atropine; Nic, nicotine; Musc, muscarine. *P < 0.05; n = 4–6.
et al., 2012). In this work, we found that application of specific
N-type Ca2+ channel blocker, ω-conotoxin GVIA (300 nM)
reduced [Ca2+]i transient by 35 ± 7% (n = 5, P < 0.05,
Figures 7A,B). In the presence of ω-conotoxin GVIA carbachol
became ineffective (Figures 7C,D), indicating that N-type Ca2+-
channels play role in presynaptic modulation observed.
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FIGURE 5 | Identification of muscarinic receptor subtypes mediating effects of cholinomimetics. (A) [Ca2+]i transients in the presence of muscarine
(10 µM) and pirenzepine (100 nM). (B) Mean values of amplitude of [Ca2+]i transients in the presence of muscarine and pirenzepine. (C) [Ca
2+]i transients in the
presence of methoctramine (10 nM) and muscarine (10 µM). (D) Mean values of amplitude of [Ca2+]i transients in the presence of methoctramine (10 nM) and
muscarine (10 µM). Abbreviations: Pirenz, pirenzepine; Musc, muscarine; Methoct, methoctramine. *P < 0.05 vs. control; n = 5.
Action of Antagonists of Nicotinic and
Muscarinic Acetylcholine Receptors on
[Ca2+]i Dynamics in the Absence of
Exogenous Cholinomimetics
Non-specific blocker of all types of nicotinic receptors, d-
tubocurarine (10 µM) increased the amplitude of [Ca2+]i
transients by 11 ± 3% (n = 15, P < 0.05, Figures 8A,B). Non-
specific blocker of muscarinic receptors, atropine (1 µM) also
increased [Ca2+]i transient by 9 ± 2% (n = 19, P < 0.05,
Figures 8C,D). When applied together, d-tubocurarine and
atropine increased the amplitude of [Ca2+]i transients by 7± 2%
(n = 7, P < 0.05), indicating the absence of additive facilitating
effects on [Ca2+]i transient. An increase in Ca
2+-response in
the presence of nicotinic or muscarinic acetylcholine receptor
blockers suggests the presence of some tonic concentration of
endogenous acetylcholine in the synaptic cleft. This acetylcholine
interacts with nicotinic and muscarinic receptors and causes
inhibition of Ca2+-ions entry into nerve terminal.
Effects of Acetylcholinesterase Inhibitor
Neostigmine on [Ca2+]i Dynamics
It has been shown earlier that anticholinesterase drugs lead
to accumulation of endogenous acetylcholine in synaptic cleft
(Loewi and Hellauer, 1938; Fatt and Katz, 1952; Fedorov,
1976). At low frequencies of motor nerve stimulation,
acetylcholinesterase inhibitor, neostigmine (1 µM), decreased
[Ca2+]i transients by 13 ± 5% (n = 5, P < 0.05, Figures 9A,B).
FIGURE 6 | Identification of nicotinic receptor subtypes mediating
effects of cholinomimetics. Mean values of magnitude of [Ca2+]i transients
in the presence of different concentrations (they are indicated in brackets) of
mecamylamine blocking various subtypes of nicotinic receptors and after
addition of nicotine (10 µM); in the presence of metillikakonitin (10 nM) and
after addition of nicotine (10 µM). Abbreviations: Nic, nicotine; Mecam,
mecamylamine. MLA, metillikakonitin. Control corresponds to 100%.
*P < 0.05 vs. control saline; n = 3–6.
This inhibitory effect of neostigmine was fully reversed in the
presence of blockers of nicotinic and muscarinic receptors
(Figure 9B). We can therefore suggest that endogenous
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FIGURE 7 | The role of voltage-gated Ca2+-channels in the effects of carbachol on [Ca2+]i dynamics. (A) [Ca
2+]i transients in the presence of specific
blocker of N-type Ca2+ channels, ω-conotoxin GVIA (300 nM). (B) Mean values of amplitudes of [Ca2+]i transients normalized to control. (C) Effect of carbachol
(10µM) on [Ca2+]i transients in the presence of ω-conotoxin GVIA. (D) Mean values of amplitudes of [Ca
2+]i transients. Abbreviations: Contr, control; ω-CTx GVIA,
ω-conotoxin GVIA; CCh, carbachol. *P < 0.05; n = 5.
acetylcholine modulates intra-terminal [Ca2+]i transients by
acting on presynaptic nicotinic and muscarinic acetylcholine
receptors.
DISCUSSION
Neurotransmitter release from frog nerve endings is modulated
by cholinomimetics: by acting through nicotinic receptors, they
change kinetics of secretion and its quantum content, while
by activation of muscarinic receptors they contribute only
to regulation of quantum content (Ciani and Edwards, 1963;
Nikolsky et al., 2004). Both quantum content and kinetics
of neurotransmitter secretion directly depend on the level of
[Ca2+]i in presynaptic terminal (Katz andMiledi, 1965; Nikol’ski˘ı
et al., 2000; Samigullin et al., 2005). Hence, modulation of
Ca2+ entry could be a plausible mechanism accounting for
inhibitory effects of cholinomimetics on quantum secretion. To
test this hypothesis, we monitored presynaptic [Ca2+]i transients
while pharmacologically manipulating acetylcholine receptors
and Ca2+ channels. In our experiments the Ca2+ probe was
loaded through the nerve stump, as described by Peng and
Zucker (1993) and Wu and Betz (1996). At the end of loading
protocol, all terminals in the proximal part of the nerve trunk
had sufficient levels of fluorescence to allow [Ca2+]i recordings.
We (in this paper), as well as others have shown that the loading
of the fluorescent dye in the nerve ending does not significantly
alter the physiological parameters of secretion, such as quantal
content and frequency of mEPC (Wu and Betz, 1996; Samigullin
et al., 2015).
We found that carbachol and acetylcholine decreased both
Ca2+ response and quantum content of EPCs, indicating that
cholinergic modulation of neurotransmitter release can be
related to changes in Ca2+ entry (Khaziev et al., 2012). We
further showed that a relatively small decrease in the driving
force for Ca2+ influx into nerve terminal causes significant
inhibition of neurotransmitter release. This was achieved by
lowering extracellular Ca2+ concentration from 0.6 to 0.3 mM
(Figures 1, 2). This observation is in a good agreement with
strong non-linear dependence of quantum content from Ca2+
entry into the presynaptic terminal (Dodge and Rahamimoff,
1967).
Inhibition of synaptic acetylcholinesterase by neostigmine
decreased [Ca2+]i transients, indicating that endogenous
acetylcholine is able to modulate Ca2+ entry into the
nerve ending. Exposure to d-tubocurarine and specific
antagonists of nicotinic receptors (in the absence of exogenous
cholinomimetics) also augmented [Ca2+]i transient, thus
indicating that tonically released ACh can block Ca2+ entry
into the presynaptic terminal. Increase of the amplitude of
[Ca2+]i transients by atropine is in a qualitative agreement
with atropine-induced increase in the secretion at frog synapses
due to elimination of tonic action of endogenous acetylcholine
as described earlier (Slutsky et al., 1999). We suggest that
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FIGURE 8 | Action of antagonists of nicotinic and muscarinic acetylcholine receptors on [Ca2+]i-dynamics in the absence of exogenous
cholinomimetics. (A) [Ca2+]i transients in control and in the presence of d-tubocurarine (10 µM); (B) mean values of amplitudes of [Ca
2+]i transients in the
presence of d-tubocurarine; (C) [Ca2+]i transients in control and in the presence of atropine (1 µM); (D) mean values of amplitudes of [Ca
2+]i transients in the
presence of atropine. Abbreviations: Contr, control; d-TC, d-tubocurarine; Atr, atropine. *P < 0.05 vs. control; n = 7–15.
FIGURE 9 | Effects of acetylcholinesterase inhibitor neostigmine on [Ca2+]i-dynamics. (A) [Ca
2+]i transients in control and in the presence of neostigmine
(1µM). (B) Mean values of amplitude of [Ca2+]i transient in the presence of acetylcholine (100 µM); in the presence of neostigmine alone and after pre-treatment by
d-tubocurarine (10 µM) and atropine (1 µM). Mean values of [Ca2+]i transient amplitude normalized to control. Effect of exogenous acetylcholine is presented for
comparison reasons. Mixture of d-tubocurarine and atropine, completely eliminated neostigmine effects on [Ca2+]i transients. Abbreviations: Contr, control; Neost,
neostigmine; ACh, acetylcholine; Atr, atropine (1 µM), d-TC, d-tubocurarine (10 µM). *P < 0.05 vs. control saline; n = 5.
release of endogenous ACh during stimulation of the motor
nerve and spontaneous quantal and non-quantal release under
physiological conditions results in modulation of presynaptic
Ca2+ entry and provides a physiologically important negative
feedback (Katz and Miledi, 1965; Vyskocil et al., 2009).
Presynaptic acetylcholine receptors of both muscarinic and
nicotinic nature are involved in this regulation. Since blockade
of M1-muscarinic receptor by pirenzepine reduced of [Ca
2+]i
transient, we may presume that activation of these receptors
could enhance Ca2+ entry. These results are in good agreement
with previous observations indicating that activation of M1
receptors enhances, whereas activation of M2 receptors inhibits
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ACh release (Slutsky et al., 1999). According to our results M2
subtype is involved in modulation of presynaptic Ca2+ entry,
because specificM2 blocker methoctramine eliminates inhibitory
effect of muscarine, whereas M1 antagonist pirenzepine has no
such effect.
Mecamylamine and metillikakonitin did not prevent the
inhibitory effect of nicotine while d-tubocurarine did. This
indicates that some d-tubocurarine-sensitive nicotinic receptors
are involved in the presynaptic inhibitory action of endogenous
acetylcholine, and inhibition of this receptor in the absence of
exogenous cholinomimetics enhances [Ca2+]i transients. Specific
N-type Ca2+-channel antagonist conotoxin GVIA removes
inhibition of [Ca2+]i transients by carbachol, pointing to a
primary role of N-type channels in providing Ca2+ entry into
the nerve terminal. Furthermore, our data about the role for
N-type of Ca2+ channels are fully compatible with earlier
results of Van der Kloot et al. (1997) who demonstrated
that ω-conotoxin eliminated effects of cholinomimetics on
quantal content in frog synapses. We conclude that in the frog
neuromuscular synapse activation of presynaptic M2 muscarinic
and d-tubocurarine-sensitive nicotinic acetylcholine receptors
by exogenous cholinomimetics and/or endogenous acetylcholine
decreases quantal content of mediator secretion by reducing the
entry of Ca2+ ions into the nerve endings due to inhibition of
voltage-gated N-type Ca2+ channels.
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